Literature DB >> 2860069

A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs.

R Kamata, T Yamamoto, K Matsumoto, H Maeda.   

Abstract

The 56-kilodalton (56K) protease isolated from a culture filtrate of Serratia marcescens caused vascular permeability enhancement followed by edema formation when injected into guinea pig peripheral corneas and subconjunctival space or skin. The character and the mechanism of permeability enhancement were analyzed in vivo. The enhancement was maximum at 5 to 10 min. The permeability reaction increased exponentially by the amount of enzyme used. The enhancement of permeability induced by the 56K protease was not affected by treatment with an antihistamine but was greatly augmented by simultaneous injection of a kinin potentiator, Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH (SQ 20,881). Furthermore, the permeability activity of the protease, but not the amidolytic activity, was inhibited by soybean trypsin inhibitor, a well-known inhibitor of plasma kallikrein, as well as by corn trypsin inhibitor, the best inhibitor of activated Hageman factor. Results of these in vivo studies indicate that the permeability-enhancing reaction induced by the 56K protease is caused by activation of the Hageman factor-dependent pathway in the tissue. The permeability-increasing activity of the 56K protease was parallel with the enzyme activity. Serratial lipopolysaccharide did not produce a permeability enhancement reaction within 30 min when injected into guinea pig skin. These results are consistent with the results of recent in vitro experiments in which activation of the purified Hageman factor but not of prekallikrein by the 56K protease was elucidated (Matsumoto et al., J. Biochem. (Tokyo) 96:739-749, 1984). Thus, the molecular mechanism described above appears to be operative in the pathogenesis of corneal edema and chemosis, which is induced by S. marcescens, in addition to the direct tissue destruction by the protease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860069      PMCID: PMC261250          DOI: 10.1128/iai.48.3.747-753.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli.

Authors:  J M Hughes; F Murad; B Chang; R L Guerrant
Journal:  Nature       Date:  1978-02-23       Impact factor: 49.962

2.  Intraocular gentamicin as intraoperative prophylaxis in South India eye camps.

Authors:  G A Peyman; M L Sathar; D R May
Journal:  Br J Ophthalmol       Date:  1977-04       Impact factor: 4.638

3.  Effects in the rat of intradermal injection of purified proteinases from streptococcus and Serratia marcescens.

Authors:  M C Conroy; N H Bander; I H Lepow
Journal:  Proc Soc Exp Biol Med       Date:  1975-12

4.  Serratia marcescens keratoconjunctivitis.

Authors:  W E Atlee; R P Burns; M Oden
Journal:  Am J Ophthalmol       Date:  1970-07       Impact factor: 5.258

5.  Simple method for quantitation of enhanced vascular permeability.

Authors:  K Udaka; Y Takeuchi; H Z Movat
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

Review 6.  Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.

Authors:  J Y Homma
Journal:  Jpn J Exp Med       Date:  1980-06

7.  Hageman factor fragment inhibitor in corn seeds: purification and characterization.

Authors:  Y Hojima; J V Pierce; J J Pisano
Journal:  Thromb Res       Date:  1980-10-15       Impact factor: 3.944

8.  Purification and characterization of a Serratia marcescens metalloprotease.

Authors:  D Lyerly; A Kreger
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

9.  Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin.

Authors:  D M Gill; S H Richardson
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

10.  Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease.

Authors:  D Lyerly; L Gray; A Kreger
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

View more
  31 in total

1.  Substance P as a potent stimulator of sneeze responses in experimental allergic rhinitis of guinea pigs.

Authors:  T Imamura; T Kambara
Journal:  Agents Actions       Date:  1992-11

2.  Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens.

Authors:  A Molla; T Akaike; H Maeda
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

Review 3.  Bacterial extracellular zinc-containing metalloproteases.

Authors:  C C Häse; R A Finkelstein
Journal:  Microbiol Rev       Date:  1993-12

4.  Activation of the plasma kallikrein-kinin system by Candida albicans proteinase.

Authors:  H Kaminishi; M Tanaka; T Cho; H Maeda; Y Hagihara
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

5.  Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture.

Authors:  A Molla; K Matsumoto; I Oyamada; T Katsuki; H Maeda
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

6.  Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections.

Authors:  W König; Y Faltin; J Scheffer; H Schöffler; V Braun
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens.

Authors:  A Molla; T Kagimoto; H Maeda
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Pseudomonas elastase acts as a virulence factor in burned hosts by Hageman factor-dependent activation of the host kinin cascade.

Authors:  I A Holder; A N Neely
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  Proteolytic activity in Serratia marcescens clinical isolates.

Authors:  R Coria-Jiménez; C Zárate-Aquino; O Ponce-Ponce
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

10.  CpxR-Dependent Thermoregulation of Serratia marcescens PrtA Metalloprotease Expression and Its Contribution to Bacterial Biofilm Formation.

Authors:  Roberto E Bruna; María Victoria Molino; Martina Lazzaro; Javier F Mariscotti; Eleonora García Véscovi
Journal:  J Bacteriol       Date:  2018-03-26       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.